Jeuveau® injection is an FDA-approved injectable treatment that temporarily improves the look of frown lines in adults.1 As a 900kDa purified botulinum toxin type A, Jeuveau has a proven molecular structure.
What else can we tell you about our product? Here are a few important things to know about Jeuveau:
Aesthetic-first and only: Clinically developed for aesthetics, Jeuveau is the first product of its kind dedicated exclusively to aesthetics. 2
Clinically Proven: Jeuveau® is backed by studies of more than 2,100 patients, including two Phase III U.S. trials, the largest head-to-head trial versus Botox® Cosmetic, as well as two long-term safety studies.3-7
You can view the published head-to-head study here: https://academic.oup.com/asj/advance-article/doi/10.1093/asj/sjz110/5428816?searchresult=1
Modern-made: Jeuveau is a modern-made neurotoxin, produced in a state-of-the-art facility using our proprietary Hi-Pure™ manufacturing process.1
For more information about Jeuveau, please see the accompanying Prescribing Information including BOXED WARNING, and Medication Guide, visit evolus.com or talk with your healthcare provider.
Please contact Botox® Cosmetic directly for information on their product.
REFERENCES: 1. United States Patent: US 9,512,418 B2; Dec. 6, 2016. 2. Jeuveau [Package Insert], Santa Barbara, CA: Evolus, Inc.; 2019. 3. Data on File, CSR EV-001, BLA761085, Evolus, Inc., Santa Barbara, CA. 4. Data on File, CSR EV-002, BLA761085, Evolus, Inc., Santa Barbara, CA. 5. Data on File, CSR EVB-003, BLA761085, Evolus, Inc., Santa Barbara, CA. 6. Data on File, CSR EV-004, BLA761085, Evolus, Inc., Santa Barbara, CA. 7. Data on File, CSR EV-006, BLA761085, Evolus, Inc., Santa Barbara, CA.